Child Psychiatry - Articles - Page 13

RESEARCH UPDATE

Pediatric Bipolar Depression: How Do We Rate a New Meta-Analysis?

October 1, 2022

Dr. Algon, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Clinicians use olanzapine, mirtazapine, and other appetite-inducing medications off label to treat ARFID, but with little research to support their use. This study unpacks the potential role of medications in treating comorbid symptoms associated with ARFID.

RESEARCH UPDATE

SSRIs and Hydroxyzine for Avoidant/Restrictive Food Intake Disorder (ARFID)?

October 1, 2022

Joshua Feder, MD

Dr. Feder, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Clinicians use olanzapine, mirtazapine, and other appetite-inducing medications off label to treat ARFID, but with little research to support their use. This study unpacks the potential role of medications in treating comorbid symptoms associated with ARFID.

RESEARCH UPDATE

Consider Catatonia in Your Differential

October 1, 2022

John Raiss, MD

John Raiss, MD. Dr. Raiss, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to discloses.

Catatonia is common in adult inpatient settings, where 6%–15% meet diagnostic criteria. In children and adolescents, prevalence estimates vary more widely, from 0.6% to 17%, perhaps because catatonia is often misdiagnosed or unrecognized. Like delirium, catatonia occurs as part of many conditions, including psychosis, mood disorders, substance use, autistic spectrum disorder, and medical conditions.

EXPERT Q&A

Assessing Sensory Processing Challenges

October 1, 2022

Virginia Spielmann PhD and Sarah A Schoen PhD, OTR/L

Virginia Spielmann, PhD, and Sarah A. Schoen, PhD, OTR/L. Executive Director (Dr. Spielmann) and Director of Research (Dr. Schoen), STAR Institute for Sensory Processing. Centennial, CO. Dr. Spielmann and Dr. Schoen, experts for this educational activity, have no relevant financial relationship(s) with ineligible companies to disclose.

Learn to identify sensory challenges to address these barriers to effective care in teens and adolescents.

EXPERT Q&A

Assessing and Treating Catatonia in Children and Adolescents

October 1, 2022

Lee Wachtel MD

Lee Wachtel, MD, Medical Director, Neurobehavioral Unit, Kennedy Krieger Institute. Psychiatry Professor, Johns Hopkins School of Medicine. Baltimore, MD.

Dr. Wachtel, expert for this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Catatonia is marked by a change from the person’s baseline state with distinct motor, vocal, and behavioral symptoms. Clinicians usually think of a catatonic person as being like a statue—immobile, unresponsive, staring, and with waxy flexibility.

Learning Objectives, Catatonia in Children and Adolescents, CCPR, Oct/Nov/Dec 2022

October 1, 2022

After reading these articles, you should be able to…

Addressing Weight Stigma in Clinical Practice

September 19, 2022

Joshua Feder, MD and Mara Goverman

Every patient and family you see is inescapably impacted by weight stigma or fat shaming and the damage from this bias can lethal.

Diagnosing and Treating Avoidant/Restrictive Food Intake Disorder

August 8, 2022

Joshua Feder, MD, Mara Goverman, and Jennifer Thomas, PhD

Nine years after DSM-5, Avoidant Restrictive Food Intake Disorder (ARFID) is still settling into clinical practice. Dr. Jennifer Thomas helps sort out the differential diagnosis between ARFID, anorexia, and other conditions and plan treatment in the context of comorbid conditions, such as anxiety disorders and Autism Spectrum Disorder.

Medication Management of Antipsychotic-Induced Weight Gain in Children and Teens

July 25, 2022

Joshua Feder, MD and Mara Goverman

Second-generation antipsychotics routinely breach the FDA’s level of concern of >7% body weight gain. This article examines the efficacy and safety of using off-label medications, such as metformin, to manage this side effect.